WHEN the Oxford team working on a Covid-19 vaccine first started holding weekly catchups in early February, Christina Dold, a 35-year-old senior postdoctoral researcher, jokingly referred to them as “Cobra” meetings. But it was in one of these early sessions that she found out how many volunteers they would be immunising daily, once the vaccine was ready to be tested. “I remember looking at a colleague. We were either going to cry or laugh, because the huge number of samples we’d have to process – potentially more than 100 a day – scared the living daylights out of us…”
This article first appeared in The Guardian on 4 July 2020. To continue reading, click here.